You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Monitoring Metabolic Energy Expenditure Via the Prosthetics of Lower Extremity Amputees
SBC: BARRON ASSOCIATES, INC. Topic: OSD11H07Limb loss affects approximately 1.9 million people in the United States, 400,000 of whom have amputations above the knee. It is well established that lower-limb amputees show greater metabolic demands during gait and more limited mobility compared to non-disabled individuals. At present, there is no lower-extremity prosthesis available that can monitor the metabolic costs of the amputee. The propo ...
SBIR Phase I 2012 Department of DefenseDefense Health Agency -
Noninvasive 3-D optical quantitative imaging of engineered tissue
SBC: DIAGNOSTIC PHOTONICS, INC. Topic: OSD11H08This project will bring interferometric synthetic aperture microscopy (ISAM), a powerful new method of computed microscopy, to bear on the problem of quantitative tissue assessment. The promise of tissue engineering, including wound healing, is limited unless the tissue is treated correctly at optimal times during growth. Therefore, continuous, nondestructive, microscopic 3-D visualization and qu ...
SBIR Phase I 2012 Department of DefenseDefense Health Agency -
Development of Biomaterial Scaffolds for Use in Regenerating Muscle Tissue
SBC: Keranetics, LLC Topic: OSD11H12Injuries to soft tissues in extremities represent a high percentage of battlefield wounds in recent conflicts. Therapies for restoring function to injured muscle are needed for Wounded Warriors suffering from debilitating and sometimes disfiguring musculoskeletal injuries. Regenerative medicine holds promises of new treatment strategies, yet there remains significant need to develop better platfo ...
SBIR Phase I 2012 Department of DefenseDefense Health Agency -
Bioactive Superporous Hydrogels with Vascular Channels for Muscle Tissue Engineering
SBC: LUNA INNOVATIONS INCORPORATED Topic: OSD11H12There is a substantial clinical need in both civilian and battlefield injuries for the repair and regeneration of large-volume-loss skeletal muscle tissue injuries. Current standards of care rely on rotational tissue grafts and often result in substantial morbidity, pain, and disfigurement. Luna Innovations Incorporated proposes the development of a hierarchically organized, superporous hydrogel c ...
SBIR Phase I 2012 Department of DefenseDefense Health Agency -
Apps for Rapid Epidemiological Analysis (AREA)
SBC: IST Research Corp. Topic: OSD11H17IST Research proposes the creation of the Disease Early Warning Sensor System. The IST Research Team will bring together considerable experience to bear on deploying technology in austere environments, developing android applications, hardening the android operating system, geospatial and temporal visualization of SMS based reporting and information collection, crowd-sourced data collections, and ...
SBIR Phase I 2012 Department of DefenseDefense Health Agency -
Medical Modeling and Simulation Based Training Return on Investment Decision Model
SBC: MYMIC, L.L.C. Topic: OSD11H19Modeling and simulation (M & S) technologies provide the capability for high-quality training in many areas of medicine while simultaneously reducing the costs and risks involved. However, M & S technologies require significant investment to realize their benefits, and it is crucial to have an appropriately designed system to best attain training objectives. The aim of this research is to develop ...
SBIR Phase I 2012 Department of DefenseDefense Health Agency -
Spatiotemporally Controlled Keratin Biomaterial Delivery System for Functional Tissue Regeneration Phase II
SBC: Keranetics, LLC Topic: OSD10H03Skeletal muscle injury is a significant challenge to warfighters due to the severity of the injuries often caused by Improvised Explosive Devices. Currently, there are few viable clinical treatment options for these types of injuries. Keratin hydrogels offer a solution to these challenges as carriers of cells and growth factors. Human epithelial keratins are the major structural proteins in cel ...
SBIR Phase II 2012 Department of DefenseDefense Health Agency -
Technologies for Treating Cartilage Tissue Loss Following Traumatic Injury
SBC: Spheringenics, Inc. Topic: OSD10H04Phase I studies demonstrate that human adipose stem cells (ASCs) exhibit characteristics of chondrocytes when cultured in chondrogenic media (CM) and this is enhanced when they are first encapsulated in low viscosity, high mannuronate content alginate beads that are less than 200fYm in diameter containing 250 cells/bead. The microencapsulated cells express mRNAs for factors associated with chondr ...
SBIR Phase II 2012 Department of DefenseDefense Health Agency -
Advanced Blood Simulant for Simulation Based Medical Trauma Training
SBC: LUNA INNOVATIONS INCORPORATED Topic: OSD10H01The proposed Phase II program is designed to build upon the successes of the Phase I feasibility study and develop an advanced blood simulant for training of combat first responders in the use of modern hemostatic products. The blood simulant will exhibit a caking/clotting response in the presence of simulated hemostatic agents while accurately approximating the viscosity and color of human blood ...
SBIR Phase II 2012 Department of DefenseDefense Health Agency -
Advanced Blood Simulant for Simulation Based Medical Trauma Training
SBC: LUNA INNOVATIONS INCORPORATED Topic: OSD10H01The aim of this proposal is to develop an advanced blood simulant to replace current simulants used in combat medical training. A successful blood simulant will exhibit a caking/clotting response in the presence of simulated hemostatic agents while accur
SBIR Phase I 2011 Department of DefenseDefense Health Agency